RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer

In vitro and in vivo evaluation of liposomes modified with polypeptides and red cell membrane as a novel drug delivery system for myocardium targeting

“…As a new class of vector extracted from living organisms, the obtained RCM-liposomes would be biocompatible with less toxicity (Fang et al, 2018;Liu et al, 2019). Indeed, our results showed that the survival rate of cells reached as high as 94.69% when treated with RCM-liposomes and showed with no significant difference when liposomes without RCM were used.…”

Segmentation techniques for early cancer detection in red blood cells with deep learning‐based classifier—a comparative approach

“…1). The images are obtained from the BCCD dataset [32] with blood samples of 200 benign and 200 malignant images from 534 patients. These images are then sent to further processing for the detection of cancer cells from normal cells.…”

Cell Membrane-Camouflaged Nanocarriers for Cancer Diagnostic and Therapeutic

“…Meanwhile, CS-6 exhibited potent antitumor efficacy by inhibiting the expression of HSP70, which can weaken the PTT effect. The resulting nanoparticles exhibited synergistic photothermalchemotherapy leading to potent in vivo antitumor efficacy (Liu et al, 2019). In another study, RGD peptide [c(RGDyC)]modified platelet vesicles were employed to co-load melanin nanoparticles (MNPs) and DOX to achieve chemo-photothermal therapy for drug-resistant tumors (Jing et al, 2018).…”